Get started
Author

Sandra Amarilla‐Quintana

Mitochondrial RNA methyltransferase TRMT61B is a new, potential biomarker and therapeutic target for highly aneuploid cancers
2022 · Alberto Martín, Carolina Epifano, et al. · Cell Death and Differentiation · 32
PDF
MEK inhibitor sensitivity in BRAF fusion-driven prostate cancer
2022 · María Dolores Fenor, Sergio Ruiz-Llorente, et al. · Clinical & Translational Oncology · 23
Consequences of Lmna Exon 4 Mutations in Myoblast Function
2020 · Déborah Gómez-Domínguez, Carolina Epifano, et al. · Cells · 15
PDF
CRISPR-mediated targeting of the LMNA c.745C>T mutation enhances survival and cardiac function in congenital muscular dystrophy
2025 · Déborah Gómez-Domínguez, Carolina Epifano, et al. · Molecular Therapy Advances · 3
CRISPR targeting of FOXL2 c. 402C >G mutation reduces malignant phenotype in granulosa tumor cells and identifies anti‐tumoral compounds
2025 · Sandra Amarilla‐Quintana, Paloma Navarro, et al. · Molecular Oncology · 2
PDF
Abstract 4475: Targeting c-MET and MAPK pathway in metastatic castration-resistant prostate cancer
2019 · Sergio Ruiz, María Dolores Fenor de la Maza, et al. · Cancer Research · 2
770 Analysis of gut microbiome in patients receiving adoptive T-cell therapy (ACT) across different solid tumour types
2020 · Arantzazu Barquin Garcia, Sergio Ruiz, et al. · Journal for ImmunoTherapy of Cancer · 1
PDF
Clinical outcome in terms of survival and treatment response of patients with metastatic urothelial carcinoma harboring FGFR alterations compared to wild-type tumors.
2020 · Elena Sevillano, Juan Francisco Rodriguez-Moreno, et al. · Journal of Clinical Oncology · 1
Author response for " CRISPR targeting of FOXL2 c. 402C >G mutation reduces malignant phenotype in granulosa tumor cells and identifies anti‐tumoral compounds"
2024 · Sandra Amarilla‐Quintana, Paloma Navarro, et al. · Publons reviews and discussion
Abstract 5288: Mechanisms of resistance to FGFR inhibitors in urothelial cancer cell lines and patients harboring FGFR3 alterations and strategies to overcome it
2020 · Sergio Ruiz-Llorente, Elena Fernández-Sevillano, et al. · Cancer Research
Abstract 4475: Targeting c-MET and MAPK pathway in metastatic castration-resistant prostate cancer
2019 · Sergio Ruiz, María Dolores Fenor de la Maza, et al. · Experimental and Molecular Therapeutics
Identification of prognostic variables in advanced ovarian cancer based on real-world patients from big data analytics.
2019 · Jesús García-Donas, Elena Sevillano, et al. · Journal of Clinical Oncology
Works count: 12
Citation count: 78
H-index: 3
I10-index: 3
Year
Topic
Type